M13T (p.Met13Thr) variant of SGCD (Delta-sarcoglycan)
M13T (p.Met13Thr) in SGCD (Delta-sarcoglycan) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Inborn genetic diseases; Autosomal recessive limb-girdle muscular dystrophy type. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data, published literature, and structural context.
M13T (p.Met13Thr) variant details
- p.Met13Thr
- rs1768841493
- ClinGen CA362007575
- ClinVar RCV002628568
- ClinVar RCV006363302
- Uncertain significance
- Inborn genetic diseases; Autosomal recessive limb-girdle muscular dystrophy type
- Missense
- Variant Prioritization Score for Impact Estimate 0.35
- ESM-1b 0.00
- AlphaMissense 0.14
- MetaLR 0.44
- MetaSVM -0.25
- PolyPhen-2 0.63
- SIFT 0.49
- ClinVar: Uncertain significance (Inborn genetic diseases; Autosomal recessive limb-girdle muscula)
- EBI: Variant of uncertain significance
- UniProt: Uncertain significance
- Population evidence available
- Structural context available
- Cited in: Specific guidelines for assessing and improving the methodological quality of economic evaluations of newborn screening. (PMID 22947299)
- Cited in: Including the initial newborn screening bloodspot collection device serial number on birth certificates: basis and… (PMID 23037933)